Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neuroprotection market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neuroprotectionmarket, defines the market attractiveness level of Neuroprotection market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neuroprotection industry, describes the types of Neuroprotection market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neuroprotection market and the development prospects and opportunities of Neuroprotection industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neuroprotection market in Chapter 13.
By Player:
Eli Lilly and Company
Daiichi Sankyo Company
Biogen
Allergan
F Hoffmann-La Roche
Novartis
Astrocyte Pharmaceuticals
Dr Reddy’s Laboratories
Teva Pharmaceutical
AstraZeneca
By Type:
Free Radical Trapping Agents (Antioxidants)
Glutamate Antagonists (Anti-Excitotoxic Agents)
Apoptosis Inhibitors
Anti-inflammatory Agents
Neurotrophic Factors (NTFs)
Metal Ion Chelators
Stimulants
Others
By End-User:
Prevention
Treatment
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neuroprotection Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neuroprotection Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neuroprotection Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neuroprotection Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neuroprotection Market Analysis and Outlook to 2022
-
7.1 Global Neuroprotection Consumption (2017-2022)
-
7.2 United States Neuroprotection Consumption (2017-2022)
-
7.3 Europe Neuroprotection Consumption (2017-2022)
-
7.4 China Neuroprotection Consumption (2017-2022)
-
7.5 Japan Neuroprotection Consumption (2017-2022)
-
7.6 India Neuroprotection Consumption (2017-2022)
-
7.7 South Korea Neuroprotection Consumption (2017-2022)
8 Region and Country-wise Neuroprotection Market Analysis and Outlook to 2028
-
8.1 Global Neuroprotection Consumption Forecast (2022-2028)
-
8.2 United States Neuroprotection Consumption Forecast (2022-2028)
-
8.3 Europe Neuroprotection Consumption Forecast (2022-2028)
-
8.4 China Neuroprotection Consumption Forecast (2022-2028)
-
8.5 Japan Neuroprotection Consumption Forecast (2022-2028)
-
8.6 India Neuroprotection Consumption Forecast (2022-2028)
-
8.7 South Korea Neuroprotection Consumption Forecast (2022-2028)
9 Global Neuroprotection Market Outlook by Types and Applications to 2022
-
9.1 Global Neuroprotection Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Free Radical Trapping Agents (Antioxidants) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Glutamate Antagonists (Anti-Excitotoxic Agents) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Apoptosis Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Anti-inflammatory Agents Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Neurotrophic Factors (NTFs) Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Metal Ion Chelators Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Stimulants Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Neuroprotection Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Prevention Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Treatment Consumption and Growth Rate (2017-2022)
10 Global Neuroprotection Market Outlook by Types and Applications to 2028
-
10.1 Global Neuroprotection Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Free Radical Trapping Agents (Antioxidants) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Glutamate Antagonists (Anti-Excitotoxic Agents) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Apoptosis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Anti-inflammatory Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Neurotrophic Factors (NTFs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Metal Ion Chelators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Stimulants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neuroprotection Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Prevention Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Treatment Consumption Forecast and Growth Rate (2022-2028)
11 Global Neuroprotection Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neuroprotection Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neuroprotection Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neuroprotection Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neuroprotection Market Competitive Analysis
-
14.1 Eli Lilly and Company
-
14.1.1 Eli Lilly and Company Company Details
-
14.1.2 Eli Lilly and Company Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly and Company Neuroprotection Product and Service
-
14.2 Daiichi Sankyo Company
-
14.2.1 Daiichi Sankyo Company Company Details
-
14.2.2 Daiichi Sankyo Company Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Daiichi Sankyo Company Neuroprotection Product and Service
-
14.3 Biogen
-
14.3.1 Biogen Company Details
-
14.3.2 Biogen Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biogen Neuroprotection Product and Service
-
14.4 Allergan
-
14.4.1 Allergan Company Details
-
14.4.2 Allergan Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Allergan Neuroprotection Product and Service
-
14.5 F Hoffmann-La Roche
-
14.5.1 F Hoffmann-La Roche Company Details
-
14.5.2 F Hoffmann-La Roche Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 F Hoffmann-La Roche Neuroprotection Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Neuroprotection Product and Service
-
14.7 Astrocyte Pharmaceuticals
-
14.7.1 Astrocyte Pharmaceuticals Company Details
-
14.7.2 Astrocyte Pharmaceuticals Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Astrocyte Pharmaceuticals Neuroprotection Product and Service
-
14.8 Dr Reddy’s Laboratories
-
14.8.1 Dr Reddy’s Laboratories Company Details
-
14.8.2 Dr Reddy’s Laboratories Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Dr Reddy’s Laboratories Neuroprotection Product and Service
-
14.9 Teva Pharmaceutical
-
14.9.1 Teva Pharmaceutical Company Details
-
14.9.2 Teva Pharmaceutical Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Teva Pharmaceutical Neuroprotection Product and Service
-
14.10 AstraZeneca
-
14.10.1 AstraZeneca Company Details
-
14.10.2 AstraZeneca Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 AstraZeneca Neuroprotection Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neuroprotection
-
Figure Neuroprotection Picture
-
Table Global Neuroprotection Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuroprotection Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuroprotection Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neuroprotection Consumption by Country (2017-2022)
-
Figure United States Neuroprotection Consumption and Growth Rate (2017-2022)
-
Table Europe Neuroprotection Consumption and Growth Rate (2017-2022)
-
Figure China Neuroprotection Consumption and Growth Rate (2017-2022)
-
Figure Japan Neuroprotection Consumption and Growth Rate (2017-2022)
-
Figure India Neuroprotection Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neuroprotection Consumption and Growth Rate (2017-2022)
-
Figure Global Neuroprotection Consumption Forecast by Country (2022-2028)
-
Figure United States Neuroprotection Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neuroprotection Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neuroprotection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neuroprotection Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neuroprotection Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neuroprotection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Free Radical Trapping Agents (Antioxidants) Consumption and Growth Rate (2017-2022)
-
Figure Global Glutamate Antagonists (Anti-Excitotoxic Agents) Consumption and Growth Rate (2017-2022)
-
Figure Global Apoptosis Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-inflammatory Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Neurotrophic Factors (NTFs) Consumption and Growth Rate (2017-2022)
-
Figure Global Metal Ion Chelators Consumption and Growth Rate (2017-2022)
-
Figure Global Stimulants Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Prevention Consumption and Growth Rate (2017-2022)
-
Figure Global Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Free Radical Trapping Agents (Antioxidants) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glutamate Antagonists (Anti-Excitotoxic Agents) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Apoptosis Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-inflammatory Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurotrophic Factors (NTFs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metal Ion Chelators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stimulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prevention Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neuroprotection Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neuroprotection Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Neuroprotection Product and Service
-
Table Daiichi Sankyo Company (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Company Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Company Neuroprotection Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Neuroprotection Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Neuroprotection Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Neuroprotection Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Neuroprotection Product and Service
-
Table Astrocyte Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Astrocyte Pharmaceuticals Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astrocyte Pharmaceuticals Neuroprotection Product and Service
-
Table Dr Reddy’s Laboratories (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy’s Laboratories Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy’s Laboratories Neuroprotection Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Neuroprotection Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Neuroprotection Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Neuroprotection Product and Service
-
